"
Team:Paris Bettencourt
From 2012.igem.org
(Difference between revisions)
| Line 27: | Line 27: | ||
<div id="sidebar"> | <div id="sidebar"> | ||
<div class="box"> | <div class="box"> | ||
| - | + | <h3>Go to</h3><br> | |
| - | + | <center><a href=https://2012.igem.org/Team:Paris_Bettencourt/Achievements> <img src=https://static.igem.org/mediawiki/2012/0/0c/ParisB_achievement_icon.png width=150></a></center> | |
| + | <br> | ||
| + | <center><a href=https://2012.igem.org/Team:Paris_Bettencourt/Overview> <img src=https://static.igem.org/mediawiki/2012/e/e8/ParisB_project_icon.png width=150></a></center> | ||
| + | <br> | ||
| + | <center><a href=https://2012.igem.org/Team:Paris_Bettencourt/Human_Practice/Frontpage> <img src=https://static.igem.org/mediawiki/2012/0/05/ParisB_human_icon.png width=150></a></center> | ||
| + | <!-- | ||
<h3>Deadlines</h3> | <h3>Deadlines</h3> | ||
<div class="date-list"> | <div class="date-list"> | ||
| Line 47: | Line 52: | ||
</ul> | </ul> | ||
</div> | </div> | ||
| + | --> | ||
</div> | </div> | ||
| Line 53: | Line 59: | ||
<ul class="list"> | <ul class="list"> | ||
<li class="first"><a href="https://2012.igem.org">iGEM 2012</a></li> | <li class="first"><a href="https://2012.igem.org">iGEM 2012</a></li> | ||
| + | <li class="first"><a href="http://partsregistry.org/Main_Page">Parts Registry</a></li> | ||
| + | <li class="first"><a href="http://www.cri-paris.org/en/cri/">The Center for Research and Interdisciplinarity</a></li> | ||
| + | |||
</ul> | </ul> | ||
</div> | </div> | ||
Revision as of 21:34, 25 September 2012
- Main
- Team
- Project
- Achievements
- Human Practice
- Safety
- Notebook
- Attributions
Overview
Delay system
Semantic containment
Restriction enzyme system
MAGE
Suicide system
Encapsulation
Synthetic import domain
Safety Questions
Safety AssessmentDuring previous years’ competitions, many iGEM teams have developed projects that propose the application of Genetically Engineered Organisms (GEO) in natural environments. However, issues of biosafety continue to complicate and constrain the use of GEOs outside the lab. A primary concern is the Horizontal Gene Transfer (HGT) of synthetic genes to natural populations. Various strategies have been developed to address this problem, providing varying levels of containment. However, the substantial elimination of HGT risks remains difficult or perhaps impossible. Read more about our project...
Go to
